Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -35.41% vs 53.87% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -102.12% vs 40.14% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -100.89% vs 58.57% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of GuiZhou SanLi Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 14.84% vs -28.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -35.41% vs 53.87% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -103.96% vs 0.94% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -102.12% vs 40.14% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -101.69% vs -11.26% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -100.89% vs 58.57% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -85.71% vs 12.90% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






